# A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

> **NCT03802617** · PHASE2 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 247 (actual)

## Conditions studied

- Uremic Pruritus

## Interventions

- **DRUG:** MR13A9
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03802617
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2019-10-22
- **Final completion:** 2019-10-22
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802617, "A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03802617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*